Studies show that miR-98 can inhibit the Wnt/β-catenin signaling pathway in hepatocellular carcinoma [47] and retinoblastoma [48], possibly explaining miR-98-5p's role in reducing ECM degradation in IL-1β-stimulated CHON-001 cells. Here, IL1B is linked to retinoblastoma.